Bioversys AG Cash Flow-to-Debt Ratio
Bioversys AG cash flow-to-debt ratio. Bioversys AG (BIOV) has a Cash Flow-to-Debt Ratio of -0.71x as of December 2025, meaning its operating cash flow of CHF-21.95 Million could theoretically repay -1% of its total liabilities (CHF30.82 Million) in one year. See BIOV free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bioversys AG (2024–2025)
Cash flow-to-debt ratio of Bioversys AG from 2024 to 2025. Historical debt coverage capacity for Bioversys AG across 2 annual periods. Also explore BIOV shareholders equity momentum to track the company's year-over-year net asset growth rate.
Bioversys AG Cash Flow-to-Debt Ratio by Year (2024–2025)
Bioversys AG cash flow-to-debt ratio by year from 2024 to 2025. Year-by-year debt coverage analysis for Bioversys AG. For the full cash flow conversion analysis, see how efficiently does Bioversys AG generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.71x | CHF-21.95 Million | CHF30.82 Million | ▼ -11.0% |
| 2024 | -0.64x | CHF-15.57 Million | CHF24.27 Million | — |